Flovent
Product Images NDC 54868-5362

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 54868-5362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

110 Mcg Label (5362)

This is a description of a medication called Flovent HFA 116MCG Inhaler which is distributed by Physicians Total Care. The NDC code and lot number of the inhaler are provided. The expiration date of the medication is also mentioned. There are additional numbers and symbols that do not provide any meaningful information regarding the medication.*

FDA Label Image

220 Mcg Label (5637)

Dist. By: PHYSICIANS TOTAL CARE, this is a medication package of FLOVENT HFA 226MCG inhaler with NDC 54868-5637-0. The lot number is 600 with an expiration date of 01/60. However, the text "T, G 7eids" and "wom asommmne" are not readable and may have been an error during .*

FDA Label Image

44 Mcg Label (5995)

This product is a Flovent HFR 44mcg inhaler distributed by Physicians Total Care with LOT 8 and an expiration date of 61460. The NDC number is 54868-5995-0.*

FDA Label Image

Fluticasone Propionate Chemical Structure (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 01)

FDA Label Image

Figure 1. A 12-week Clinical Trial In Patients Aged ≥12 Years Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (study 1) (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 02)

The text mentions some data related to % Change From Basel, Placebo, and a medication called FLOVENT HFA 88 mcg. There is also a chart with dates and some ticks. It is not clear what the endpoint is.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Patients Aged ≥12 Years Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (study 2) (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 03)

This is a chart displaying the percentage change from baseline in FEV for different treatments (placebo, FLOVENT HFA 88 mcg twice daily, FLOVENT HFA 220 mcg twice daily, and FLOVENT HFA 440 mcg twice daily) over an evaluation period of 12 endpoints.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Patients Aged ≥12 Years Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 04)

The text is a chart showing the percentage of patients with a reduction or increase in dose when taking either a placebo or FLOVENT HFA at varying doses.*

FDA Label Image

Figure 1 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 05)

FDA Label Image

Figure 2 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 06)

FDA Label Image

Figure 3 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 07)

FDA Label Image

Figure 4 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.